Team:WashU/DesignSynecho
From 2012.igem.org
(Difference between revisions)
Line 7: | Line 7: | ||
<h1>Phase II</h1> | <h1>Phase II</h1> | ||
<h3>Design</h3> | <h3>Design</h3> | ||
+ | The purpose of phase II is to optimize the expression of the proteins necessary for the production of crocin glycosides and safranal. Unfortunately, ZCD has been shown to produce inclusion bodies when expressed'' in vivo'' in ''E. coli'' and so an alternative method needed to be developed to create a functional protein. This was done by following the technique described by Florence Bouvier (The Plant Cell, vol. 15 47-62). | ||
<body> | <body> | ||
<img src="https://static.igem.org/mediawiki/igem.org/2/2f/Thiofusion_diagram_2.jpg" ALIGN=RIGHT width="786" border="0" usemap="#map" > | <img src="https://static.igem.org/mediawiki/igem.org/2/2f/Thiofusion_diagram_2.jpg" ALIGN=RIGHT width="786" border="0" usemap="#map" > |
Revision as of 02:51, 15 September 2012